Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.2%
    Check dated 2026-10-24T22:39:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-17T22:44:44.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-10T22:32:39.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The version history shows repeated updates to the study status and eligibility sections, documenting how the trial record has evolved over time. These edits reflect ongoing management and refinement of the trial's public information.
    Difference
    0.0%
    Check dated 2026-09-26T22:16:46.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the Record History as the latest update to the study record. Revision: v3.6.6 was removed from the history.
    Difference
    0.0%
    Check dated 2026-09-19T22:24:42.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Update to the page's revision history showing Revision: v3.6.6, replacing the previous v3.6.5. This reflects a newer platform release entry for this study record history.
    Difference
    0.0%
    Check dated 2026-08-29T18:48:30.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.